BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8922919)

  • 21. [Functional decoupling of left ventricular beta-adrenoceptor in a canine model of obesity-hypertension].
    Cabrol P; Galinier M; Fourcade J; Verwaerde P; Massabuau P; Tran MA; Montastruc JL; Bounhoure JP; Fauvel JM; Sénard JM
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1021-4. PubMed ID: 9749157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Left ventricular ejection dynamics in apical hypertrophy, a form of hypertrophic nonobstructive cardiomyopathy].
    Stierle U; Sheikhzadeh A; Diederich KW; Langbehn AF; Fröschlin R
    Herz; 1985 Apr; 10(2):72-83. PubMed ID: 3157632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological quantification and differentiation of left ventricular hypertrophy in hypertrophic cardiomyopathy and hypertensive heart disease. A two dimensional echocardiographic study.
    Keller H; Wanger KC; Goepfrich M; Stegaru B; Buss J; Heene DL
    Eur Heart J; 1990 Jan; 11(1):65-74. PubMed ID: 2137778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Beta-adrenergic receptivity and left ventricular hypertrophy caused by pressure overload in man].
    Galinier M; Senard JM; Valet P; Glock Y; Fournial G; Cerene A; Puel J; Montastruc JL; Bounhoure JP
    Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1099-103. PubMed ID: 8129508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes.
    Cerrato F; Pacileo G; Limongelli G; Gagliardi MG; Santoro G; Digilio MC; Di Salvo G; Ardorisio R; Miele T; Calabrò R
    Cardiol Young; 2008 Dec; 18(6):575-80. PubMed ID: 18842161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in cardiac beta-adrenoceptors in human heart diseases: relationship to the degree of heart failure and further evidence for etiology-related regulation of beta 1 and beta 2 subtypes.
    Steinfath M; Lavicky J; Schmitz W; Scholz H; Döring V; Kalmár P
    J Cardiothorac Vasc Anesth; 1993 Dec; 7(6):668-73. PubMed ID: 7905755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echocardiographic assessment of left ventricular hypertrophy in patients with obstructive or nonobstructive hypertrophic cardiomyopathy.
    Maron BJ
    Eur Heart J; 1983 Nov; 4 Suppl F():73-91. PubMed ID: 6686547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy.
    Hagège AA; Dubourg O; Desnos M; Mirochnik R; Isnard G; Bonne G; Carrier L; Guicheney P; Bouhour JB; Schwartz K; Komajda M
    Eur Heart J; 1998 Mar; 19(3):490-9. PubMed ID: 9568454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy].
    Fattori R; Rapezzi C; Castriota F; Magnani G; Bertaccini P; Galiè N; Magnani B; Gavelli G
    Radiol Med; 1994; 88(1-2):36-43. PubMed ID: 8066253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients.
    Kelm M; Schäfer S; Mingers S; Heydthausen M; Vogt M; Motz W; Strauer BE
    J Hypertens; 1996 Nov; 14(11):1357-64. PubMed ID: 8934365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy.
    Sai E; Shimada K; Yokoyama T; Hiki M; Sato S; Hamasaki N; Maruyama M; Morimoto R; Miyazaki T; Fujimoto S; Tamura Y; Aoki S; Watada H; Kawamori R; Daida H
    Heart Vessels; 2017 Feb; 32(2):166-174. PubMed ID: 27142065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia.
    Schäfers M; Lerch H; Wichter T; Rhodes CG; Lammertsma AA; Borggrefe M; Hermansen F; Schober O; Breithardt G; Camici PG
    J Am Coll Cardiol; 1998 Jul; 32(1):181-6. PubMed ID: 9669268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early diastolic dysfunction of the left ventricle affected by hypertrophy and abnormal histopathology in hypertrophic cardiomyopathy].
    Sugihara N; Shimizu M; Suematsu T; Horita Y; Shimizu K; Ohsato K; Shibayama S; Nakao T; Kitamura M; Takeda R
    J Cardiol; 1990; 20(1):71-81. PubMed ID: 2151236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy.
    Wagner JA; Sax FL; Weisman HF; Porterfield J; McIntosh C; Weisfeldt ML; Snyder SH; Epstein SE
    N Engl J Med; 1989 Mar; 320(12):755-61. PubMed ID: 2537929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy : quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography.
    Wichter T; Schäfers M; Rhodes CG; Borggrefe M; Lerch H; Lammertsma AA; Hermansen F; Schober O; Breithardt G; Camici PG
    Circulation; 2000 Apr; 101(13):1552-8. PubMed ID: 10747349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
    J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myocardial beta-adrenergic receptors and left ventricular hypertrophy induced by pressure overload in man].
    Galinier M; Sénard JM; Dréan G; Valet P; Glock Y; Dalous P; Roux D; Puel J; Montastruc JL; Bounhoure JP
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1113-7. PubMed ID: 1336354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tricuspid annular motion velocity as a differentiation index of hypertrophic cardiomyopathy from hypertensive heart disease.
    Hayashi S; Yamada H; Nishio S; Hotchi J; Bando M; Takagawa Y; Saijo Y; Hirata Y; Sata M
    J Cardiol; 2015 Jun; 65(6):519-25. PubMed ID: 25199979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta adrenoceptor density in patients with left-sided valvular regurgitation.
    Dzimiri N; Moorji A
    Fundam Clin Pharmacol; 1996; 10(6):547-53. PubMed ID: 8985725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.